UAE – The Abu Dhabi Department of Health, the Abu Dhabi Investment Office (ADIO), Etihad Airways, and AD Ports Group have entered a strategic partnership to strengthen Abu Dhabi’s capabilities as a global pharmaceutical and life sciences distribution hub. 

This collaboration aims to leverage the emirate’s strategic location, lucrative investment opportunities, and advanced logistics capabilities to create attractive value propositions for pharmaceutical, biotechnology, and medical technology companies.

The partnership was signed during the BIO International Convention 2024 in San Diego, in the US, and is aligned with the Abu Dhabi Economic Vision 2030. 

The agreement aims to position Abu Dhabi as a global healthcare and life-science distribution hub, enhance its role in global pharmaceutical supply chains, and ensure timely access to innovative healthcare products for patients across the region.

Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innovation Centre at DoH, emphasized the importance of this initiative, stating, “Leveraging Abu Dhabi’s strategic location at the gateway to the MENA region, we are pleased to partner with world-class leaders in investment and logistics, offering advanced infrastructure with easy access to regional and global markets. 

“Our vision is to create a healthcare environment where patients have access to the latest treatments and medical technologies.” She stated. 

The partnership includes plans to support local manufacturing and packaging of pharmaceutical and biotechnology products and enhance local capability. 

It is expected to attract significant investment in healthcare and logistics, promoting sustainable economic growth and diversification within the healthcare and life sciences sectors.

 Badr Al-Olama, Director General of ADIO, highlighted Abu Dhabi’s commitment to supporting the healthcare and life sciences industry, stating that the Emirates stands as a leading hub in this field, with advanced infrastructure and supportive regulations enabling a vibrant community of health-tech companies.

 Stanislas Brun, Vice President of Etihad Cargo, emphasized the company’s commitment to supporting Abu Dhabi’s vision of becoming a global hub for healthcare and life sciences distribution, stating that this partnership is a major step towards enhancing the UAE’s strategic importance in the international pharmaceutical supply chain and ensuring greater access to innovative healthcare products for patients in the region and beyond.

 Mansoor Al Marar, Vice President, Industrial Business Development at KEZAD Group, expressed excitement about the partnership, stating that it represents a significant step forward in establishing Abu Dhabi as a premier global pharmaceutical and life sciences distribution hub. 

 He added that this partnership will enhance Abu Dhabi’s regional and global competitiveness and ensure timely access to innovative healthcare products by leveraging KEZAD Group’s strategic location, world-class logistics infrastructure, and robust investment environment.

 The partnership is a significant step forward in Abu Dhabi’s efforts to become a leading healthcare destination in the global healthcare landscape, driving economic growth and job creation for Emirati citizens in the healthcare and logistics sectors.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook